Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer MJ Fackler, Z Lopez Bujanda, C Umbricht, WW Teo, S Cho, Z Zhang, ... Cancer research 74 (8), 2160-2170, 2014 | 197 | 2014 |
Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment. Cancer Immunol Res. 2017; 5 (11): 992–1004. doi: 10.1158/2326-6066 Y Muroyama, TR Nirschl, CM Kochel, Z Lopez-Bujanda, D Theodros, ... CIR-17-0040.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 2017 | 180* | 2017 |
Monitoring of serum DNA methylation as an early independent marker of response and survival in metastatic breast cancer: TBCRC 005 prospective biomarker study K Visvanathan, MJS Fackler, Z Zhang, ZA Lopez-Bujanda, SC Jeter, ... Journal of Clinical Oncology 35 (7), 751, 2017 | 112 | 2017 |
Molecular profiling of human mammary gland links breast cancer risk to a p27+ cell population with progenitor characteristics S Choudhury, V Almendro, VF Merino, Z Wu, R Maruyama, Y Su, ... Cell stem cell 13 (1), 117-130, 2013 | 109 | 2013 |
Blocking IL1 beta promotes tumor regression and remodeling of the myeloid compartment in a renal cell carcinoma model: multidimensional analyses DH Aggen, CR Ager, AZ Obradovic, N Chowdhury, A Ghasemzadeh, ... Clinical Cancer Research 27 (2), 608-621, 2021 | 89 | 2021 |
Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression. Nature Cancer 2, 803–818, 2021 | 77 | 2021 |
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies Z Lopez-Bujanda, CG Drake Journal of leukocyte biology 102 (2), 393-406, 2017 | 63 | 2017 |
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model YC Shen, A Ghasemzadeh, CM Kochel, TR Nirschl, BJ Francica, ... Prostate cancer and prostatic diseases 21 (1), 113-125, 2018 | 55 | 2018 |
Overexpression of MEOX2 and TWIST1 Is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis F Avila-Moreno, L Armas-Lopez, AM Alvarez-Moran, Z Lopez-Bujanda, ... PloS one 9 (12), e114104, 2014 | 44 | 2014 |
A DNA hypomethylating drug alters the tumor microenvironment and improves the effectiveness of immune checkpoint inhibitors in a mouse model of pancreatic cancer TA Gonda, J Fang, M Salas, C Do, E Hsu, A Zhukovskaya, A Siegel, ... Cancer research 80 (21), 4754-4767, 2020 | 41 | 2020 |
Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation C Le Magnen, RK Virk, A Dutta, JY Kim, S Panja, ZA Lopez-Bujanda, ... Disease models & mechanisms 11 (11), dmm035139, 2018 | 37 | 2018 |
Comparative study of breast cancer in Mexican and Mexican-American women ME Martínez, LE Gutiérrez-Millan, M Bondy, A Daneri-Navarro, ... Health 2 (09), 1040, 2010 | 29 | 2010 |
Do breast cancer cell lines provide a relevant model of the patient tumor methylome? LM Cope, MJ Fackler, Z Lopez-Bujanda, AC Wolff, K Visvanathan, ... PloS one 9 (8), e105545, 2014 | 27 | 2014 |
TGM4: an immunogenic prostate-restricted antigen ZA Lopez-Bujanda, A Obradovic, TR Nirschl, L Crowley, R Macedo, ... Journal for immunotherapy of cancer 9 (6), 2021 | 14 | 2021 |
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy JE Hawley, S Pan, WD Figg, ZA Lopez‐Bujanda, JD Strope, DH Aggen, ... The Prostate 80 (4), 336-344, 2020 | 12 | 2020 |
Gene methylation and cytological atypia in random fine-needle aspirates for assessment of breast cancer risk V Stearns, MJ Fackler, S Hafeez, ZL Bujanda, RT Chatterton, LK Jacobs, ... Cancer prevention research 9 (8), 673-682, 2016 | 10 | 2016 |
Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and its use S Sukumar, MJ Fackler, WW Teo, ZAL Bujanda, A Wolff US Patent 10,450,609, 2019 | 5 | 2019 |
Combining androgen deprivation with immune checkpoint blockade delays the development of castration resistance in a murine model of prostate cancer YC Shen, C Kochel, BJ Francica, A Alme, C Nirschl, T Nirschl, ... Cancer Research 75 (15_Supplement), 267-267, 2015 | 5 | 2015 |
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen ZA Lopez-Bujanda, MG Chaimowitz, TD Armstrong, JB Foote, LA Emens, ... Oncoimmunology 9 (1), 1809926, 2020 | 3 | 2020 |
Correction: Overexpression of MEOX2 and TWIST1 is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis F Ávila-Moreno, L Armas-López, AM Álvarez-Moran, Z López-Bujanda, ... Plos one 11 (2), e0146569, 2016 | 3 | 2016 |